Related Experiment Videos
The niacin skin flush test in schizophrenia: a replication study.
1MRI Unit, MRC Clinical Sciences Centre, Imperial College School of Medicine, Hammersmith Hospital, London.
International Journal of Clinical Practice
|August 15, 2001
Summary
The niacin skin flush test may help diagnose schizophrenia by detecting impaired signal transduction. This non-invasive test showed significantly reduced responses in schizophrenia patients compared to controls.
Area of Science:
- Neuroscience
- Psychiatry
- Biochemistry
Background:
- Schizophrenia is a complex psychiatric disorder.
- Arachidonic acid metabolism is implicated in schizophrenia pathophysiology.
- Niacin-induced skin flush reflects vascular response and signal transduction.
Purpose of the Study:
- To validate the niacin skin flush test for assessing arachidonic acid-related signal transduction in schizophrenia.
- To confirm previous findings on the test's utility in schizophrenia diagnosis.
Main Methods:
- A non-invasive niacin skin flush test using methyl nicotinate solution.
- Assessed skin flush response over 20 minutes in 21 schizophrenia patients and 20 controls.
- Compared response levels between patient and control groups.
Main Results:
- Significantly lower niacin-induced skin flush response in schizophrenia patients.
- At 0.001 M methyl nicotinate and 15 minutes, 2/21 patients responded vs. 15/20 controls (p < 0.00002).
- The test demonstrated 90% sensitivity and 75% specificity for schizophrenia.
Conclusions:
- Results support the niacin skin flush test's ability to detect impaired signal transduction in schizophrenia.
- The test shows potential as a clinical diagnostic tool for schizophrenia.
- Further research is warranted to explore its clinical application.